Form 4: scPharmaceuticals Director Frederick M. Hudson Acquires Stock Options
SEC Form 4 Filing
Director Frederick M. Hudson of scPharmaceuticals Inc. reports acquisition of stock options.
Summary
- Frederick M. Hudson, a director of scPharmaceuticals Inc., filed a Form 4 with the SEC.
- The filing reports the acquisition of 19,750 stock options on June 11, 2024, at an exercise price of $4.11.
- These options vest fully on the earlier of June 11, 2025, or the next annual meeting of the Issuer's stockholders.
- Following the transaction, Hudson directly owns 19,750 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. The director's confidence in the company is a slightly positive indicator.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of stock option acquisition. |
| 06/11/2025 | Date of full vesting of stock options (or earlier at next annual meeting). |
| 06/11/2034 | Expiration date of the stock options. |
| 06/13/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.